2.23
+0.06(+2.77%)
Currency In USD
| Previous Close | 2.17 |
| Open | 2.15 |
| Day High | 2.33 |
| Day Low | 2.15 |
| 52-Week High | 3.1 |
| 52-Week Low | 0.94 |
| Volume | 104,369 |
| Average Volume | 226,723 |
| Market Cap | 37.58M |
| PE | -1.74 |
| EPS | -1.28 |
| Moving Average 50 Days | 1.44 |
| Moving Average 200 Days | 1.45 |
| Change | 0.06 |
If you invested $1000 in Unity Biotechnology, Inc. (UBX) since IPO date, it would be worth $13.39 as of February 05, 2025 at a share price of $2.23. Whereas If you bought $1000 worth of Unity Biotechnology, Inc. (UBX) shares 5 years ago, it would be worth $33.79 as of February 05, 2025 at a share price of $2.23.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
UNITY Biotechnology Reports Granting of New Employment Inducement Award
GlobeNewswire Inc.
Jan 07, 2025 9:10 PM GMT
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025,
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire Inc.
Jan 06, 2025 1:00 PM GMT
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with th
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
GlobeNewswire Inc.
Nov 04, 2024 9:30 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the thi